The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 120,070 | 938,490 | SH | SOLE | 938,490 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 2,990 | 35,200 | SH | SOLE | 35,200 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 47,143 | 662,958 | SH | SOLE | 662,958 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 7,573 | 228,595 | SH | SOLE | 228,595 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 86,642 | 952,847 | SH | SOLE | 952,847 | 0 | 0 | ||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 718 | 61,313 | SH | SOLE | 61,313 | 0 | 0 | ||
| GENERATION BIO CO | COM | 37148K100 | 5,590 | 197,191 | SH | SOLE | 197,191 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 9,204 | 199,269 | SH | SOLE | 199,269 | 0 | 0 | ||
| INHIBRX INC | COM | 45720L107 | 1,205 | 36,534 | SH | SOLE | 36,534 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 57,299 | 260,876 | SH | SOLE | 260,876 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 19,589 | 114,900 | SH | SOLE | 114,900 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 372 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||